| General Information of This Metabolic Reaction (MR) (ID:
MR010610) |
| Formula |
|
| Reactant |
N-0923 Metabolite M12 |
Product |
N-0923 Metabolite M13 |
|
Reactant Info
|
Product Info
|
|
Metabolic Type
|
Unclear
-
Unclear
|
|
|
|
|
|
|
|
| Other MR(s) Related to The Reactant of This MR |
|
Other MR(s) That Produce The Reactant of This MR
|
|
|
|
Other MR(s) That Metabolize The Reactant of This MR
|
|
|
| References |
| 1 |
Determination of the dopamine D2 agonist N-0923 and its major metabolites in perfused rat livers by HPLC-UV-atmospheric pressure ionization mass spectrometry
|
| 2 |
Absorption, disposition, metabolic fate, and elimination of the dopamine agonist rotigotine in man: administration by intravenous infusion or transdermal delivery
|
| 3 |
No influence of the CYP2C19-selective inhibitor omeprazole on the pharmacokinetics of the dopamine receptor agonist rotigotine
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.